Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Investor Lawsuit Targets Replimune (REPL) After FDA Deems RP1 Trial Inadequate - Hagens Berman

(NASDAQ:REPL) SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- A new securities class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) and its executives. The lawsuit alleges ...

What precedent does this case set for other biotech firms and how could it influence market perception of similar clinical trial disclosures? How might the alleged misstatement about RP1's trial results affect the company's pipeline credibility and future financing? What immediate effect will the lawsuit have on REPL's stock volatility and price?
Symbol: REPL
Lawsuits
8 days ago
Read more prnewswire

Sable Offshore (SOC) Sued for Misleading Investors on Oil Production – Hagens Berman

(NYSE:SOC) SAN FRANCISCO--(BUSINESS WIRE)--A newly filed class-action lawsuit targets Sable Offshore Corp. (NYSE: SOC) and its executives, alleging the company misrepresented its oil production sta...

How does this legal risk compare to similar litigation faced by other mid‑cap oil producers, and what does it mean for the sector’s broader risk profile? What is the likelihood of the secondary public offering being delayed or canceled due to the legal allegations? How will the lawsuit and potential settlement affect Sable Offshore’s stock price and volatility in the short term?
Symbol: SOC
Lawsuits
8 days ago
Read more businesswire

James Hardie Industries (JHX) Stock Plunges Amid Inventory “Destocking” Revelation -- Hagens Berman

(NYSE:JHX) SAN FRANCISCO--(BUSINESS WIRE)--On August 20, 2025, James Hardie Industries (NYSE: JHX) shares crashed by 34% after the company disclosed significant issues with its North America busine...

How does this news change James Hardie's valuation relative to its industry peers and affect our position sizing or risk management strategy? What are the potential financial ramifications if Hagens Berman’s investigation confirms that investors were misled about sales practices? How will the North American inventory destocking impact James Hardie's short‑term cash flow and earnings guidance?
Symbol: JHX
Lawsuits
8 days ago
Read more businesswire

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

(CBSC) Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical

What are the key risks and upside scenarios—regulatory, currency, integration—that could materially impact the long‑term value of this partnership? What market share and competitive positioning gains can CBSC expect in Costa Rica, Panama, Colombia, and Argentina relative to its peers? How will the exclusive 5‑year distribution agreement affect CBSC’s revenue and earnings forecasts for the next fiscal periods?
Symbol: CBSC
Partnership
8 days ago
Read more globenewswire